Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma

References

• Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc Natl Acad Sci USA 2007; 104:20007-12; PMID:18077431; http://dx.doi.org/10.1073/pnas.0710052104
   PubMed Web of Science ®Google Scholar
• McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM, Olson JJ, Mikkelsen T, Lehman N, Aldape K, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455:1061-8; PMID:18772890; http://dx.doi.org/10.1038/nature07385
   PubMed Web of Science ®Google Scholar
• Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321:1807-12; PMID:18772396; http://dx.doi.org/10.1126/science.1164382
   PubMed Web of Science ®Google Scholar
• Gunther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Westphal M, Lamszus K. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008; 27:2897-909; PMID:18037961; http://dx.doi.org/10.1038/sj.onc.1210949
   PubMed Web of Science ®Google Scholar
• Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 2014; 344:1396-401; PMID:24925914; http://dx.doi.org/10.1126/science.1254257
   PubMed Web of Science ®Google Scholar
• Bachoo RM, Maher EA, Ligon KL, Sharpless NE, Chan SS, You MJ, Tang Y, DeFrances J, Stover E, Weissleder R, et al. Epidermal growth factor receptor and Ink4a/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002; 1:269-77; PMID:12086863; http://dx.doi.org/10.1016/S1535-6108(02)00046-6
   PubMed Web of Science ®Google Scholar
• Uhrbom L, Dai C, Celestino JC, Rosenblum MK, Fuller GN, Holland EC. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res 2002; 62:5551-8; PMID:12359767
   PubMed Web of Science ®Google Scholar
• Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9:157-73; PMID:16530701; http://dx.doi.org/10.1016/j.ccr.2006.02.019
   PubMed Web of Science ®Google Scholar
• Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17:98-110; PMID:20129251; http://dx.doi.org/10.1016/j.ccr.2009.12.020
   PubMed Web of Science ®Google Scholar
• Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 2007; 9:424-9; PMID:17622647; http://dx.doi.org/10.1215/15228517-2007-023
   PubMed Web of Science ®Google Scholar
• Gilbertson RJ, Gutmann DH. Tumorigenesis in the brain: Location, location, location. Cancer Res 2007; 67:5579-82; PMID:17575119; http://dx.doi.org/10.1158/0008-5472.CAN-07-0760
   PubMedGoogle Scholar
• Haskins WE, Zablotsky BL, Foret MR, Ihrie RA, Alvarez-Buylla A, Eisenman RN, Berger MS, Lin CH. Molecular characteristics in MRI-classified group 1 glioblastoma multiforme. Front Oncol 2013; 3:182; PMID:23875172; http://dx.doi.org/10.3389/fonc.2013.00182
   PubMedGoogle Scholar
• Alvarez-Buylla A, Lim DA. For the long run: Maintaining germinal niches in the adult brain. Neuron 2004; 41:683-6; PMID:15003168; http://dx.doi.org/10.1016/S0896-6273(04)00111-4
   PubMed Web of Science ®Google Scholar
• Stangeland B, Mughal AA, Grieg Z, Sandberg CJ, Joel M, Nygard S, Meling T, Murrell W, Vik Mo EO, Langmoen IA. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Oncotarget 2015; 6:26192-215; PMID:26295306; http://dx.doi.org/10.18632/oncotarget.4613
   PubMedGoogle Scholar
• Altaner C. Glioblastoma and stem cells. Neoplasma 2008; 55:369-74; PMID:18665745
   PubMed Web of Science ®Google Scholar
• Sandstrom RS, Foret MR, Grow DA, Haugen E, Rhodes CT, Cardona AE, Phelix CF, Wang Y, Berger MS, Lin CH. Epigenetic regulation by chromatin activation mark H3K4me3 in primate progenitor cells within adult neurogenic niche. Sci Rep 2014; 4:5371; PMID:24947819; http://dx.doi.org/10.1038/srep05371
   PubMed Web of Science ®Google Scholar
• Rhodes CT, Sandstrom RS, Huang SA, Wang Y, Schotta G, Berger MS, Lin CA. Cross-species analyses unravel the complexity of H3K27me3 and H4K20me3 in the context of neural stem progenitor cells. Neuroepigenetics 2016; 6:10-25; PMID:27429906; http://dx.doi.org/10.1016/j.nepig.2016.04.001
   PubMedGoogle Scholar
• Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005; 8:323-35; PMID:16226707; http://dx.doi.org/10.1016/j.ccr.2005.09.001
   PubMed Web of Science ®Google Scholar
• Sharma MK, Mansur DB, Reifenberger G, Perry A, Leonard JR, Aldape KD, Albin MG, Emnett RJ, Loeser S, Watson MA, et al. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res 2007; 67:890-900; PMID:17283119; http://dx.doi.org/10.1158/0008-5472.CAN-06-0973
   PubMed Web of Science ®Google Scholar
• Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell 2013; 153:38-55; PMID:23540689; http://dx.doi.org/10.1016/j.cell.2013.03.008
   PubMed Web of Science ®Google Scholar
• Sassone-Corsi P. Physiology. When metabolism and epigenetics converge. Science 2013; 339:148-50; PMID:23307727; http://dx.doi.org/10.1126/science.1233423
   PubMedGoogle Scholar
• Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010; 18:553-67; PMID:21130701; http://dx.doi.org/10.1016/j.ccr.2010.11.015
   PubMed Web of Science ®Google Scholar
• Mazor T, Pankov A, Johnson BE, Hong C, Hamilton EG, Bell RJ, Smirnov IV, Reis GF, Phillips JJ, Barnes MJ, et al. DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors. Cancer Cell 2015; 28:307-17; PMID:26373278; http://dx.doi.org/10.1016/j.ccell.2015.07.012
   PubMed Web of Science ®Google Scholar
• Mazor T, Pankov A, Song JS, Costello JF. Intratumoral heterogeneity of the epigenome. Cancer Cell 2016; 29:440-51; PMID:27070699; http://dx.doi.org/10.1016/j.ccell.2016.03.009
   PubMed Web of Science ®Google Scholar
• Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010; 17:225-34; PMID:20171147; http://dx.doi.org/10.1016/j.ccr.2010.01.020
   PubMed Web of Science ®Google Scholar
• Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2010; 465:966; PMID:20559394; http://dx.doi.org/10.1038/nature09132
   PubMed Web of Science ®Google Scholar
• Verdaasdonk JS, Bloom K. Centromeres: Unique chromatin structures that drive chromosome segregation. Nat Rev Mol Cell Biol 2011; 12:320-32; PMID:21508988; http://dx.doi.org/10.1038/nrm3107
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004; 432:396-401; PMID:15549107; http://dx.doi.org/10.1038/nature03128
   PubMed Web of Science ®Google Scholar
• Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F, Vescovi AL. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006; 444:761-5; PMID:17151667; http://dx.doi.org/10.1038/nature05349
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756-60; PMID:17051156; http://dx.doi.org/10.1038/nature05236
   PubMed Web of Science ®Google Scholar
• Thomas L, Di Stefano AL, Ducray F. Predictive biomarkers in adult gliomas: The present and the future. Curr Opin Oncol 2013; 25:689-94; PMID:24076583; http://dx.doi.org/10.1097/CCO.0000000000000002
   PubMed Web of Science ®Google Scholar
• Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352:997-1003; PMID:15758010; http://dx.doi.org/10.1056/NEJMoa043331
   PubMed Web of Science ®Google Scholar